Novo Integrated Sciences, Inc.
NVOS
$0.065
$0.009316.70%
| 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.75% | 1,103.01% | 16.91% | 8.74% | 7.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.75% | 1,103.01% | 16.91% | 8.74% | 7.11% |
| Cost of Revenue | -0.88% | 399.94% | 22.42% | 17.31% | 9.81% |
| Gross Profit | 15.95% | 29.53% | 9.62% | -2.18% | 3.20% |
| SG&A Expenses | 4.08% | 8.92% | -1.75% | -6.04% | -6.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.29% | 108.93% | 5.63% | 0.95% | -0.93% |
| Operating Income | 2.80% | -1.09% | 7.39% | 7.99% | 10.77% |
| Income Before Tax | -21.55% | 25.56% | 65.41% | 60.23% | 59.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.55% | 25.51% | 65.39% | 60.21% | 59.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -169.58% | -92.09% | -93.52% | -81.86% | -71.98% |
| Net Income | -22.34% | 25.10% | 65.27% | 60.09% | 59.77% |
| EBIT | 2.80% | -1.09% | 7.39% | 7.99% | 10.77% |
| EBITDA | 3.17% | -2.76% | 4.88% | 2.83% | 4.82% |
| EPS Basic | 55.92% | 84.76% | 92.67% | 89.61% | 81.00% |
| Normalized Basic EPS | 60.52% | 67.00% | 86.45% | 82.04% | 64.76% |
| EPS Diluted | 55.92% | 84.76% | 92.67% | 89.61% | 81.00% |
| Normalized Diluted EPS | 60.52% | 67.00% | 86.45% | 82.04% | 64.76% |
| Average Basic Shares Outstanding | 77.67% | 136.14% | 265.67% | 336.88% | 248.37% |
| Average Diluted Shares Outstanding | 77.67% | 136.14% | 265.67% | 336.88% | 248.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
